ICD-10 Logo
ICDxICD-10 Medical Coding
ICD-10 Logo
ICDxICD-10 Medical Coding
ICD 10 CodesDiagnoses
ICD 10 CodesDiagnoses
ICD-10 Logo
ICDxICD-10 Medical Coding

Comprehensive ICD-10-CM code reference with AI-powered search capabilities.

© 2025 ICD Code Compass. All rights reserved.

Browse

  • All Chapters
  • All Categories
  • Diagnoses

Tools

  • AI Code Search
ICD-10-CM codes are maintained by the CDC and CMS. This tool is for reference purposes only.
v1.0.0
ICD-10 Guide
ICD-10 CodesD75.83

D75.83

Billable

Thrombocytosis

BILLABLE STATUSYes
IMPLEMENTATION DATEOctober 1, 2015
LAST UPDATED09/05/2025

Code Description

ICD-10 D75.83 is a billable code used to indicate a diagnosis of thrombocytosis.

Key Diagnostic Point:

Thrombocytosis is a hematological condition characterized by an elevated platelet count in the blood, typically defined as a platelet count greater than 450,000 platelets per microliter. This condition can be classified into primary thrombocytosis, which is often due to myeloproliferative disorders, and secondary thrombocytosis, which can occur in response to various physiological stimuli such as inflammation, infection, or iron deficiency. Thrombocytosis can lead to an increased risk of thrombotic events, including stroke and myocardial infarction, due to the hypercoagulable state it creates. Clinically, patients may be asymptomatic or present with symptoms related to thrombosis, such as headaches, dizziness, or visual disturbances. The diagnosis is typically made through complete blood count (CBC) tests, and further evaluation may be necessary to determine the underlying cause, especially in cases of secondary thrombocytosis. Management strategies depend on the underlying etiology and may include therapeutic phlebotomy, antiplatelet therapy, or treatment of the underlying condition.

Code Complexity Analysis

Complexity Rating: Medium

Medium Complexity

Complexity Factors

  • Differentiating between primary and secondary thrombocytosis
  • Understanding the underlying causes and associated conditions
  • Interpreting laboratory results accurately
  • Documenting clinical scenarios that may affect coding

Audit Risk Factors

  • Inadequate documentation of platelet counts
  • Failure to specify primary vs. secondary thrombocytosis
  • Lack of supporting clinical information for diagnosis
  • Misinterpretation of laboratory results

Specialty Focus

Medical Specialties

Hematology

Documentation Requirements

Detailed lab results, patient history, and treatment plans.

Common Clinical Scenarios

Patients presenting with elevated platelet counts, symptoms of thrombosis, or those undergoing treatment for myeloproliferative disorders.

Billing Considerations

Ensure clear documentation of the underlying cause of thrombocytosis and any associated conditions.

Oncology

Documentation Requirements

Comprehensive cancer history, treatment regimens, and response to therapy.

Common Clinical Scenarios

Patients with malignancies that may cause secondary thrombocytosis or those receiving chemotherapy.

Billing Considerations

Document the relationship between cancer treatment and platelet count changes.

Coding Guidelines

Inclusion Criteria

Use D75.83 When
  • According to ICD
  • 10 guidelines, D75
  • 83 should be used when a patient has a documented elevated platelet count without a known underlying cause
  • It is important to ensure that the diagnosis is supported by laboratory findings and clinical documentation

Exclusion Criteria

Do NOT use D75.83 When
No specific exclusions found.

Related ICD-10 Codes

Related CPT Codes

85027CPT Code

Complete blood count (CBC) with differential

Clinical Scenario

Used to diagnose and monitor thrombocytosis.

Documentation Requirements

Document the reason for the CBC and any relevant clinical findings.

Specialty Considerations

Hematologists may require additional tests to determine the cause of thrombocytosis.

ICD-10 Impact

Diagnostic & Documentation Impact

Enhanced Specificity

ICD-10 Improvements

The transition to ICD-10 has allowed for more specific coding of thrombocytosis, enabling better tracking of the condition and its causes, which can improve patient management and outcomes.

ICD-9 vs ICD-10

The transition to ICD-10 has allowed for more specific coding of thrombocytosis, enabling better tracking of the condition and its causes, which can improve patient management and outcomes.

Reimbursement & Billing Impact

The transition to ICD-10 has allowed for more specific coding of thrombocytosis, enabling better tracking of the condition and its causes, which can improve patient management and outcomes.

Resources

Clinical References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Coding & Billing References

  • •
    ICD-10-CM Official Guidelines for Coding and Reporting

Frequently Asked Questions

What is the difference between primary and secondary thrombocytosis?

Primary thrombocytosis is caused by intrinsic bone marrow disorders, while secondary thrombocytosis is a reactive process due to other conditions such as infection or inflammation.